Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebocontrolled, phase 3 trial (vol 19, pg 1437, 2018)

Shitara K.; Doi T.; Dvorkin M.

首页> 外文期刊>The lancet oncology >Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebocontrolled, phase 3 trial (vol 19, pg 1437, 2018)

【24h】

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebocontrolled, phase 3 trial (vol 19, pg 1437, 2018)

机译：Trifluridine / Tipiracil与Houndbo患者患有重症预处理的转移性胃癌（标签）：随机，双盲，不安放的，第3阶段试验（Vol 19，PG 1437,2018）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet oncology》 |2018年第12期|共1页
作者
Shitara K.; Doi T.; Dvorkin M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebocontrolled, phase 3 trial (vol 19, pg 1437, 2018) [J] . Shitara K., Doi T., Dvorkin M. The lancet oncology . 2018,第12期

机译：Trifluridine / Tipiracil与Houndbo患者患有重症预处理的转移性胃癌（标签）：随机，双盲，不安放的，第3阶段试验（Vol 19，PG 1437,2018）
2. The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer [J] . Van Cutsem Eric, Mayer Robert J., Laurent Stephanie, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：Trifluridine / Tipiracil（Tas-102）的III期递交试验的亚组与转移结直肠癌患者最佳支持性护理的安慰剂
3. The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer [J] . Xiaoyan He, Tianyao Zhang, Lijuan Wu, Medicine. . 2021,第2期

机译：Trifluridine / Tipiracil对重症预处理转移性胃癌患者的影响
4. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
5. A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer [O] . Manish R. Patel, Gerald S. Falchook, Kensuke Hamada, 2021

机译：Trifluridine / Tipiracil Plus Nivolumab患者患者的第2期试验患者重新预处理微卫星稳定的转移结直肠癌
6. Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial [O] . 2017

机译：在西班牙转移性结直肠癌患者的随机对照试验中，三氟吡啶和替吡西酯（TAS-102）与安慰剂联合支持治疗的疗效：RECOURSE 3期试验的亚组分析结果

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebocontrolled, phase 3 trial (vol 19, pg 1437, 2018)

著录项

相似文献

相关主题

期刊订阅